Log In
Print
BCIQ
Print
Print this Print this
 

Nefecon (PL-56)

Also known as: Nefigan

  Manage Alerts
Collapse Summary General Information
Company Pharmalink AB
DescriptionEnteric formulation of a locally acting corticosteroid that downregulates the kidney's inflammatory process
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationGlomerulonephritis
Indication DetailsTreat IgA nephropathy
Regulatory Designation

U.S. - Orphan Drug (Treat IgA nephropathy)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today